- 专利标题： CDCP1-TARGETED THERAPIES
-
申请号： US17292257申请日： 2019-11-07
-
公开(公告)号： US20220119545A1公开(公告)日： 2022-04-21
- 发明人: Lewis C. CANTLEY , Stephen P. SOLTOFF , Brooke M. EMERLING , George POULOGIANNIS , Cindy M. HODAKOSKI , Hui LIU , Irina APOSTOLOU , Brian Gaither BATES , Kimberly Ann MARQUETTE , Eric M. BENNETT , Lidia MOSYAK , Lioudmila G. TCHISTIAKOVA , Edward Christian ROSFJORD , Isaac J. RONDON , Chao Bai HUANG
- 申请人： Beth Israel Deaconess Medical Center , Pfizer Inc. , Cornell University
- 申请人地址： US MA Boston; US NY New york; US NY Mew York
- 专利权人： Beth Israel Deaconess Medical Center,Pfizer Inc.,Cornell University
- 当前专利权人： Beth Israel Deaconess Medical Center,Pfizer Inc.,Cornell University
- 当前专利权人地址： US MA Boston; US NY New york; US NY Mew York
- 国际申请： PCT/US19/60276 WO 20191107
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61P35/00
摘要：
The present disclosure provides materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy.
信息查询
